Newsroom

Sorted by: Latest
-

Integrated DNA Technologies Invests in New Research, Development and Innovation Center in San Francisco Bay Area

SUNNYVALE, Calif.--(BUSINESS WIRE)--Integrated DNA Technologies announces a strategic move, expanding its San Francisco Bay Area presence to serve the vibrant biotechnology community....
-

A.R.I. Announces Growth Capital Investment in October’s Very Own (OVO)

LOS ANGELES & TORONTO & TAMPA, Fla.--(BUSINESS WIRE)--Zack Ellison's A.R.I. announces a growth capital investment in October’s Very Own (OVO), the globally recognized lifestyle brand founded by Drake....
-

Kaplan and HerMD Founder Dr. Somi Javaid Hold Webinar to Spotlight Menopause and Critical Issues in Women’s Midlife Health

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Kaplan to host free webinar on menopause on January 27 at 1 PM ET with Dr. Somi Javaid, board-certified OB/GYN, surgeon, and founder of HerMD....
-

Peachtree Group Announces Bill Deutsch as Senior Vice President, Equipment Finance

ATLANTA--(BUSINESS WIRE)--Peachtree Group announced that Bill Deutsch has joined its Equipment Finance division as senior vice president....
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - October 12.01.2026 FOCT.LN IE0004X8KUG5 50,002.00 USD 1,380,729.93 27.614  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 12.01.2026 FJUL.LN IE000YJBT6I5 100,002.00 USD 2,704,249.54 27.042  ...
-

L’agent IA biologique spécialisé Pathology Explorer d’Owkin est lancé avec Claude d’Anthropic pour les soins de santé et les sciences de la vie

SAN FRANCISCO--(BUSINESS WIRE)--Owkin, une entreprise spécialisée dans l’IA dont la mission est de résoudre la complexité de la biologie, a annoncé aujourd’hui que son agent IA interopérable Pathology Explorer sera inclus dans le lancement de Claude pour les soins de santé et les sciences de la vie (HCLS) par Anthropic. C’est la première fois qu’un agent biologique hautement spécialisé et leader mondial, formé principalement à partir de données multimodales sur les patients, est accessible via...
-

Riassunto: È ora disponibile l'agente AI biologico specializzato di Owkin, Pathology Explorer, lanciato con Claude for Healthcare and Life Sciences

SAN FRANCISCO--(BUSINESS WIRE)--Owkin, azienda AI che persegue la missione di risolvere la complessità della biologia, oggi annuncia che il suo agente AI interoperabile Pathology Explorer sarà incluso nel lancio di Claude for Healthcare and Life Sciences (HCLS) di Anthropic; per la prima volta un vasto pubblico di professionisti della sanità e delle scienze della vita potrà accedere tramite il Model Context Protocol (MCP) a un agente biologico ad alta specializzazione, leader a livello mondiale...
-

Owkins spezialisierter biologischer KI-Agent Pathology Explorer wird mit Anthropics Claude für das Gesundheitswesen und die Biowissenschaften eingeführt

SAN FRANCISCO--(BUSINESS WIRE)--Owkin, ein KI-Unternehmen, das sich zum Ziel gesetzt hat, die Komplexität der Biologie zu entschlüsseln, hat heute bekannt gegeben, dass sein interoperabler KI-Agent Pathology Explorer in die Einführung von „Claude for Healthcare and Life Sciences (HCLS)“ durch Anthropic integriert wird. Dies ist das erste Mal, dass ein hochspezialisierter, weltweit führender biologischer Wirkstoff, der in erster Linie auf multimodalen Patientendaten trainiert wurde, über das Mod...
-

Resumen: Pathology Explorer, el agente de IA biológico especializado de Owkin, se lanza junto con Claude for Healthcare and Life Sciences de Anthropic

SAN FRANCISCO--(BUSINESS WIRE)--Owkin, una empresa de IA que tiene la misión de resolver las complejidades de la biología, anunció hoy que Pathology Explorer, su agente de IA interoperable, estará incluido en el lanzamiento de Claude for Healthcare and Life Sciences (HCLS) de Anthropic. Es la primera vez que se puede acceder a un agente biológico altamente especializado y líder a nivel mundial, entrenado principalmente con datos de pacientes multimodales a través de Model Context Protocol (MCP)...